2022 Q1 Form 10-Q Financial Statement

#000155837022008947 Filed on May 16, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $0.00 $363.0K
YoY Change -100.0%
Cost Of Revenue $0.00 $225.0K
YoY Change -100.0%
Gross Profit $0.00 $138.0K
YoY Change -100.0%
Gross Profit Margin 38.02%
Selling, General & Admin $1.409M $1.330M
YoY Change 5.94% 15.65%
% of Gross Profit 963.77%
Research & Development $108.0K $826.0K
YoY Change -86.92% 1.98%
% of Gross Profit 598.55%
Depreciation & Amortization $36.00K $46.00K
YoY Change -21.74% -23.33%
% of Gross Profit 33.33%
Operating Expenses $1.517M $2.159M
YoY Change -29.74% 9.98%
Operating Profit -$1.517M -$2.021M
YoY Change -24.94% 2.95%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $4.000K
YoY Change
Pretax Income -$1.490M -$2.020M
YoY Change -26.24% 3.06%
Income Tax
% Of Pretax Income
Net Earnings -$1.490M -$2.021M
YoY Change -26.27% 2.95%
Net Earnings / Revenue -556.75%
Basic Earnings Per Share -$0.05 -$0.07
Diluted Earnings Per Share -$0.05 -$0.07
COMMON SHARES
Basic Shares Outstanding 31.83M 30.53M
Diluted Shares Outstanding 31.83M 30.53M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.667M $10.73M
YoY Change -37.87% 51.55%
Cash & Equivalents $6.667M $10.73M
Short-Term Investments
Other Short-Term Assets $401.0K $580.0K
YoY Change -30.86% 56.76%
Inventory
Prepaid Expenses
Receivables $27.00K $120.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $7.339M $11.43M
YoY Change -35.79% 53.22%
LONG-TERM ASSETS
Property, Plant & Equipment $493.0K $760.0K
YoY Change -35.13% 28.81%
Goodwill
YoY Change
Intangibles $802.0K
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.00K $10.00K
YoY Change 0.0% 0.0%
Total Long-Term Assets $1.305M $2.060M
YoY Change -36.65% 6.74%
TOTAL ASSETS
Total Short-Term Assets $7.339M $11.43M
Total Long-Term Assets $1.305M $2.060M
Total Assets $8.644M $13.49M
YoY Change -35.92% 43.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $294.0K $440.0K
YoY Change -33.18% -58.49%
Accrued Expenses $196.0K $380.0K
YoY Change -48.42% 31.03%
Deferred Revenue $84.00K
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $786.0K $870.0K
YoY Change -9.66% -37.86%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $250.0K
YoY Change -100.0%
Other Long-Term Liabilities $294.0K $510.0K
YoY Change -42.35% 34.21%
Total Long-Term Liabilities $294.0K $760.0K
YoY Change -61.32% 100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $786.0K $870.0K
Total Long-Term Liabilities $294.0K $760.0K
Total Liabilities $1.080M $1.630M
YoY Change -33.74% -8.43%
SHAREHOLDERS EQUITY
Retained Earnings -$84.30M
YoY Change
Common Stock $3.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.564M $11.87M
YoY Change
Total Liabilities & Shareholders Equity $8.644M $13.49M
YoY Change -35.92% 43.66%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$1.490M -$2.021M
YoY Change -26.27% 2.95%
Depreciation, Depletion And Amortization $36.00K $46.00K
YoY Change -21.74% -23.33%
Cash From Operating Activities -$1.503M -$1.513M
YoY Change -0.66% 8.85%
INVESTING ACTIVITIES
Capital Expenditures $5.000K $54.00K
YoY Change -90.74% -167.5%
Acquisitions
YoY Change
Other Investing Activities $23.00K
YoY Change
Cash From Investing Activities -$15.00K -$88.00K
YoY Change -82.95% 10.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 578.0K 3.502M
YoY Change -83.5%
NET CHANGE
Cash From Operating Activities -1.503M -1.513M
Cash From Investing Activities -15.00K -88.00K
Cash From Financing Activities 578.0K 3.502M
Net Change In Cash -940.0K 1.901M
YoY Change -149.45% -229.32%
FREE CASH FLOW
Cash From Operating Activities -$1.503M -$1.513M
Capital Expenditures $5.000K $54.00K
Free Cash Flow -$1.508M -$1.567M
YoY Change -3.77% 19.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31826221
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30526571
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001434524
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 clir Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm
P0Y
CY2022Q1 clir Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm
P0Y
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32154746
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31581666
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-35521
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
CLEARSIGN TECHNOLOGIES CORPORATION
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WA
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-2056298
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
8023 E. 63rd Place, Suite 101
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Tulsa
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
OK
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
74133
CY2022Q1 dei City Area Code
CityAreaCode
206
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
673-4848
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2022Q1 dei Trading Symbol
TradingSymbol
CLIR
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32160131
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6667000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7607000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
27000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
33000
CY2022Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
244000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
294000
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
39000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
401000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
345000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
7339000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
8024000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
493000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
530000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
802000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
799000
CY2021Q4 us-gaap Assets
Assets
9363000
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
84000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
84000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
786000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
731000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
294000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
350000
CY2022Q1 us-gaap Liabilities
Liabilities
1080000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10000
CY2022Q1 us-gaap Assets
Assets
8644000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1409000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1333000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
1517000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
224000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
212000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
205000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
196000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
218000
CY2021Q4 us-gaap Liabilities
Liabilities
1081000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32154746
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31581666
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
3000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
91807000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
91035000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
9000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
9000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-84255000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-82765000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
7564000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
8282000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7564000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8282000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8644000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9363000
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
363000
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
225000
CY2021Q1 us-gaap Gross Profit
GrossProfit
138000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
108000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
826000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
2159000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1517000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2021000
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
23000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1490000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30526571
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8282000
CY2022Q1 clir Common Stock Issued For Exercise Of Options0.89 Per Share
CommonStockIssuedForExerciseOfOptions0.89PerShare
0.89
CY2022Q1 clir Common Stock Issued For Exercise Of Options2.93 Per Share
CommonStockIssuedForExerciseOfOptions2.93PerShare
2.93
CY2022Q1 clir Stock Issued During Period Value In Payments Of Accrued Compensation
StockIssuedDuringPeriodValueInPaymentsOfAccruedCompensation
95000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2021000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31826221
CY2022Q1 clir Stock Options Granted In Payment Of Accrued Compensation Fair Value
StockOptionsGrantedInPaymentOfAccruedCompensationFairValue
12000
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
80000
CY2022Q1 clir Share Issued For At Market Issuance1.24 Per Share
ShareIssuedForAtMarketIssuance1.24PerShare
1.24
CY2022Q1 clir Shares Issued Through Use Of At Market Issuance
SharesIssuedThroughUseOfAtMarketIssuance
578000
CY2022Q1 clir Common Stock For Services Per Share Issue One
CommonStockForServicesPerShareIssueOne
1.93
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
7000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1490000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7564000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9541000
CY2021Q1 clir Common Stock Issued For Exercise Of Options1.90 Per Share
CommonStockIssuedForExerciseOfOptions1.90PerShare
1.90
CY2021Q1 clir Stock Issued During Period Value Stock Options Exercised1.90 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised1.90PerShare
2000
CY2021Q1 clir Common Stock Issued For Exercise Of Options3.80 Per Share
CommonStockIssuedForExerciseOfOptions3.80PerShare
3.80
CY2021Q1 clir Stock Issued During Period Value Stock Options Exercised3.80 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised3.80PerShare
36000
CY2021Q1 clir Common Stock Issued For Exercise Of Options1.21 Per Share
CommonStockIssuedForExerciseOfOptions1.21PerShare
1.21
CY2021Q1 clir Stock Issued During Period Value Stock Options Exercised1.21 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised1.21PerShare
4000
CY2021Q1 clir Common Stock Issued For Exercise Of Options1.80 Per Share
CommonStockIssuedForExerciseOfOptions1.80PerShare
1.80
CY2021Q1 clir Shares Issued Upon Exercise Of Warrants
SharesIssuedUponExerciseOfWarrants
67000
CY2021Q1 clir Adjustments To Additional Paid In Capital Share Based Payment Arrangement Option Increase For Cost Recognition Two
AdjustmentsToAdditionalPaidInCapitalShareBasedPaymentArrangementOptionIncreaseForCostRecognitionTwo
210000
CY2021Q1 clir Stock Issued During Period Value In Payments Of Accrued Compensation
StockIssuedDuringPeriodValueInPaymentsOfAccruedCompensation
217000
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
410000
CY2021Q1 clir Share Issued For At Market Issuance4.84 Per Share
ShareIssuedForAtMarketIssuance4.84PerShare
4.84
CY2021Q1 clir Shares Issued Through Use Of At Market Issuance
SharesIssuedThroughUseOfAtMarketIssuance
4469000
CY2021Q1 clir Proceeds Receivable From At Market Issuance
ProceedsReceivableFromAtMarketIssuance
1076000
CY2021Q1 clir Common Stock For Services Per Share Issue Two
CommonStockForServicesPerShareIssueTwo
2.33
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
9000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-2021000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11868000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1490000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-2021000
CY2022Q1 clir Common Stock Issued For Services
CommonStockIssuedForServices
7000
CY2021Q1 clir Common Stock Issued For Services
CommonStockIssuedForServices
9000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
80000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
620000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
36000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
46000
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
23000
CY2021Q1 clir Reserve For Prepaid Materials
ReserveForPrepaidMaterials
96000
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
205000
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
247000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
124000
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
56000
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-127000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-940000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1901000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7607000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8824000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
57000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
85000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
25000
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-46000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1503000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1513000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
54000
CY2022Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
33000
CY2021Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
34000
CY2022Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
23000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-88000
CY2022Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
578000
CY2021Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3393000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
578000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3502000
CY2021Q1 clir Proceeds From Exercise Of Stock Options
ProceedsFromExerciseOfStockOptions
109000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6667000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10725000
CY2022Q1 clir Officer And Employee Equity Awards For Prior Year Accrued Compensation
OfficerAndEmployeeEquityAwardsForPriorYearAccruedCompensation
107000
CY2021Q1 clir Officer And Employee Equity Awards For Prior Year Accrued Compensation
OfficerAndEmployeeEquityAwardsForPriorYearAccruedCompensation
217000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-84300000
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2022Q1 us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3100000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
417000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
453000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
212000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
205000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
294000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
350000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
506000
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3300000
CY2022Q1 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Before Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation
1082000
CY2021Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Before Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation
1132000
CY2022Q1 clir Property Plant And Equipment And Operating Lease Right Of Use Asset Excluding Construction In Progress Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetExcludingConstructionInProgressAccumulatedDepreciationAndAmortization
1006000
CY2021Q4 clir Property Plant And Equipment And Operating Lease Right Of Use Asset Excluding Construction In Progress Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetExcludingConstructionInProgressAccumulatedDepreciationAndAmortization
1055000
CY2022Q1 clir Property Plant And Equipment Excluding Lessor Asset Under Operating Lease And Construction In Progress After Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAndConstructionInProgressAfterAccumulatedDepreciation
76000
CY2021Q4 clir Property Plant And Equipment Excluding Lessor Asset Under Operating Lease And Construction In Progress After Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAndConstructionInProgressAfterAccumulatedDepreciation
77000
CY2022Q1 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
417000
CY2021Q4 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
453000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
493000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
530000
CY2022Q1 us-gaap Depreciation
Depreciation
7000
CY2021Q1 us-gaap Depreciation
Depreciation
8000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
555000
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
57000
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
51000
CY2022Q1 us-gaap Payments For Rent
PaymentsForRent
57000
CY2021Q1 us-gaap Payments For Rent
PaymentsForRent
53000
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
320000
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M6D
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.058
CY2022Q1 clir Lessee Operating Lease Liability Discounted Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityDiscountedPaymentsRemainderOfFiscalYear
158000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
176000
CY2022Q1 clir Lessee Operating Lease Liability Discounted Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths
122000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
136000
CY2022Q1 clir Lessee Operating Lease Liability Discounted Payments Due Year Two
LesseeOperatingLeaseLiabilityDiscountedPaymentsDueYearTwo
54000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
64000
CY2022Q1 clir Lessee Operating Lease Liability Discounted Payments Due Year Three
LesseeOperatingLeaseLiabilityDiscountedPaymentsDueYearThree
59000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
66000
CY2022Q1 clir Lessee Operating Lease Liability Discounted Payments Due Year Four
LesseeOperatingLeaseLiabilityDiscountedPaymentsDueYearFour
63000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
67000
CY2022Q1 clir Lessee Operating Lease Liability Discounted Payments Due After Year Four
LesseeOperatingLeaseLiabilityDiscountedPaymentsDueAfterYearFour
50000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
51000
CY2022Q1 clir Lessee Operating Lease Liability Discounted Payments Due
LesseeOperatingLeaseLiabilityDiscountedPaymentsDue
506000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
560000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
56000
CY2022Q1 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
1050000
CY2021Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
1016000
CY2022Q1 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
96000
CY2021Q4 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
97000
CY2022Q1 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
8000
CY2021Q4 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
8000
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1154000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1121000
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
352000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
322000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
802000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
799000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
9000
CY2022Q1 clir Finite Lived Intangible Assets Amortization Expense Due After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseDueAfterYearFour
11000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3039000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.03
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
88000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
96000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
74000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
42000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
320000
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
363000
CY2020 clir Residual Cost On Completed Contract
ResidualCostOnCompletedContract
8000
CY2022Q1 us-gaap Contract With Customer Asset Change In Method Credit Loss Expense Reversal
ContractWithCustomerAssetChangeInMethodCreditLossExpenseReversal
51000
CY2022Q1 clir Expired Of Reversal For Product Warranties
ExpiredOfReversalForProductWarranties
3
CY2022Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
244000
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
39000
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
84000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
84000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
62500000
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000.0
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y8M15D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.7764
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0139
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
42000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
410000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2964000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.06
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M20D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
88000
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.26
CY2022Q1 clir Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P9Y9M3D
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3000
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.89
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
10000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.93
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y9M3D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2202000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.71
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y18D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
848000
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1800000

Files In Submission

Name View Source Status
0001558370-22-008947-index-headers.html Edgar Link pending
0001558370-22-008947-index.html Edgar Link pending
0001558370-22-008947.txt Edgar Link pending
0001558370-22-008947-xbrl.zip Edgar Link pending
clir-20220331.xsd Edgar Link pending
clir-20220331x10q.htm Edgar Link pending
clir-20220331x10q_htm.xml Edgar Link completed
clir-20220331xex31d1.htm Edgar Link pending
clir-20220331xex31d2.htm Edgar Link pending
clir-20220331xex32d1.htm Edgar Link pending
clir-20220331_cal.xml Edgar Link unprocessable
clir-20220331_def.xml Edgar Link unprocessable
clir-20220331_lab.xml Edgar Link unprocessable
clir-20220331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending